Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP268833.RA_a_pocMtgKL5XUu5oR0cgGwnxsxFRmtxf246ri_3wNg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP268833.RA_a_pocMtgKL5XUu5oR0cgGwnxsxFRmtxf246ri_3wNg130_assertion type Assertion NP268833.RA_a_pocMtgKL5XUu5oR0cgGwnxsxFRmtxf246ri_3wNg130_head.
- NP268833.RA_a_pocMtgKL5XUu5oR0cgGwnxsxFRmtxf246ri_3wNg130_assertion description "[According to the LOH study at intragenic polymorphic sites, deletion of Bcl10 in informative cases was detected in 50% of malignant mesotheliomas, 33% of gastric carcinomas, 23% of breast carcinomas, 20% of hepatocellular carcinomas, 17% of lymphomas, 15% of colorectal carcinomas, 13% of laryngeal carcinomas, and 10% of male germ cell tumors (GCTs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP268833.RA_a_pocMtgKL5XUu5oR0cgGwnxsxFRmtxf246ri_3wNg130_provenance.
- NP268833.RA_a_pocMtgKL5XUu5oR0cgGwnxsxFRmtxf246ri_3wNg130_assertion evidence source_evidence_literature NP268833.RA_a_pocMtgKL5XUu5oR0cgGwnxsxFRmtxf246ri_3wNg130_provenance.
- NP268833.RA_a_pocMtgKL5XUu5oR0cgGwnxsxFRmtxf246ri_3wNg130_assertion SIO_000772 10582682 NP268833.RA_a_pocMtgKL5XUu5oR0cgGwnxsxFRmtxf246ri_3wNg130_provenance.
- NP268833.RA_a_pocMtgKL5XUu5oR0cgGwnxsxFRmtxf246ri_3wNg130_assertion wasDerivedFrom befree-2016 NP268833.RA_a_pocMtgKL5XUu5oR0cgGwnxsxFRmtxf246ri_3wNg130_provenance.
- NP268833.RA_a_pocMtgKL5XUu5oR0cgGwnxsxFRmtxf246ri_3wNg130_assertion wasGeneratedBy ECO_0000203 NP268833.RA_a_pocMtgKL5XUu5oR0cgGwnxsxFRmtxf246ri_3wNg130_provenance.